13-Valent Pneumococcal Conjugate Vaccine



13-Valent Pneumococcal Conjugate Vaccine

Target Group: Persons aged from 6 weeks to 5 years

Function: Stimulate the body to produce humoral immune response. Prevent invasive diseases caused by pneumococcal serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F (including bacteremic pneumonia, meningitis, septicemia and bacteremia).